Tranexamic Acid
Tranexamic acid is administered in AFE to inhibit fibrinolysis and help stabilize clot formation. Fibrinolysis inhibition is one of three critical treatment targets in AFE management alongside volume replacement and right ventricular suppo…
1 sources - 2 claims
Tranexamic acid is administered in AFE to inhibit fibrinolysis and help stabilize clot formation. Fibrinolysis inhibition is one of three critical treatment targets in AFE management alongside volume replacement and right ventricular support.